Phreesia (NYSE:PHR) General Counsel Sells $112,010.85 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison Hoffman sold 6,585 shares of Phreesia stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total transaction of $112,010.85. Following the completion of the sale, the general counsel owned 174,762 shares of the company’s stock, valued at $2,972,701.62. This represents a 3.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Phreesia Stock Down 2.8%

Shares of NYSE PHR opened at $16.12 on Thursday. The firm has a market cap of $971.77 million, a PE ratio of -161.17 and a beta of 0.61. Phreesia, Inc. has a 12-month low of $15.41 and a 12-month high of $32.76. The company’s fifty day simple moving average is $18.59 and its 200 day simple moving average is $23.48. The company has a quick ratio of 2.44, a current ratio of 2.44 and a debt-to-equity ratio of 0.01.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 8th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.11. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The firm had revenue of $120.33 million during the quarter, compared to the consensus estimate of $119.98 million. During the same period in the previous year, the firm posted ($0.25) earnings per share. The business’s revenue was up 12.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Institutional Trading of Phreesia

A number of institutional investors have recently added to or reduced their stakes in PHR. Squarepoint Ops LLC raised its position in Phreesia by 243.6% in the 2nd quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock worth $2,872,000 after purchasing an additional 71,553 shares during the period. Farther Finance Advisors LLC grew its stake in shares of Phreesia by 9,375.0% during the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after buying an additional 3,000 shares during the last quarter. Arcadia Investment Management Corp MI increased its holdings in shares of Phreesia by 22.3% in the second quarter. Arcadia Investment Management Corp MI now owns 113,470 shares of the company’s stock worth $3,229,000 after buying an additional 20,700 shares during the period. Acadian Asset Management LLC lifted its stake in shares of Phreesia by 61.6% in the 2nd quarter. Acadian Asset Management LLC now owns 364,194 shares of the company’s stock valued at $10,357,000 after acquiring an additional 138,877 shares during the last quarter. Finally, Boston Partners boosted its holdings in Phreesia by 165.1% during the 2nd quarter. Boston Partners now owns 130,060 shares of the company’s stock valued at $3,702,000 after acquiring an additional 81,006 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on PHR shares. Robert W. Baird dropped their price objective on shares of Phreesia from $31.00 to $25.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 10th. Canaccord Genuity Group dropped their target price on Phreesia from $38.00 to $33.00 and set a “buy” rating on the stock in a report on Tuesday, December 9th. Royal Bank Of Canada began coverage on Phreesia in a research report on Friday, January 9th. They set a “moderate buy” rating and a $26.00 target price on the stock. KeyCorp reduced their price objective on shares of Phreesia from $35.00 to $32.00 and set an “overweight” rating for the company in a research report on Wednesday, October 8th. Finally, Mizuho dropped their price target on Phreesia from $36.00 to $28.00 and set an “outperform” rating on the stock in a report on Wednesday, December 10th. Seventeen investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Phreesia has a consensus rating of “Moderate Buy” and a consensus price target of $30.06.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.